Anthony Bergmann - 03 Mar 2025 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Linda Marban, Attorney-in-Fact
Issuer symbol
CAPR
Transactions as of
03 Mar 2025
Net transactions value
+$3,475
Form type
4
Filing time
04 Mar 2025, 19:00:17 UTC
Previous filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAPR Common Stock Options Exercise $3,475 +2,500 +44% $1.39 8,223 03 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAPR Stock Option (Right to Buy) Options Exercise $0 -2,500 -100% $0.000000 0 03 Mar 2025 Common Stock 2,500 $1.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 3, 2015 and was previously reported as covering 25,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
F2 Shares vested 1/48th on the first day of each month commencing April 1, 2015.